Comparison of abbreviated MRI and ultrasonography in the detection of early hepatocellular carcinoma: a meta-analysis.
Jialin Liu, Pengyuan Zhong, Wenqi Ma et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis compared abbreviated magnetic resonance imaging (AMRI) with ultrasonography (US) for detecting early-stage hepatocellular carcinoma. Nine studies involving 1,914 participants were included. Pooled sensitivity was 83% (95% confidence interval [CI]: 76%-88%) for AMRI and 47% (95% CI: 34%-61%) for US; specificity was 96% (95% CI: 93%-97%) and 91% (95% CI: 84%-95%), respectively. AMRI also had a higher pooled area under the curve, and its detection rate was significantly greater than US (risk ratio = 1.39, 95% CI: 1.16-1.67, P < 0.001).
Key findings
- AMRI sensitivity was 83% (95% confidence interval [CI]: 76%-88%), compared with 47% (95% CI: 34%-61%) for US.
- AMRI specificity was 96% (95% CI: 93%-97%); US specificity was 91% (95% CI: 84%-95%).
- AMRI’s pooled area under the curve was 0.91 (95% CI: 0.88-0.93), versus 0.78 (95% CI: 0.74-0.82) for US.
- AMRI detection rate exceeded US (risk ratio = 1.39, 95% CI: 1.16-1.67, P < 0.001); subgroup results varied with enhancement status.
Why it matters
Early HCC detection is clinically important, and the pooled results suggest AMRI may identify more early-stage cancers than US while also showing higher specificity. These comparative estimates can inform evaluation of imaging approaches for screening, but they do not by themselves establish which strategy improves patient outcomes.
What to keep in mind
The meta-analysis included nine studies, and subgroup findings were confounded by whether AMRI was enhanced, limiting the certainty of comparisons across AMRI approaches.